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Determination of reliable bioindicators of diabetes-induced ox-
idative stress and the role of dietary vitamin E supplementation
were investigated. Blood (plasma) chemistries, lipid peroxidation
(LPO), and antioxidant enzyme activities were measured over
12 weeks in New Zealand White rabbits (control, diabetic, and dia-
betic+vitaminE).Cholesterolandtriglyceridelevelsdidnotcorre-
latewithdiabeticstate.PlasmaLPOwasinﬂuencedbydiabetesand
positively correlated with glucose concentration only, not choles-
terol or triglycerides. Liver glutathione peroxidase (GPX) activity
negatively correlated with glucose and triglyceride levels. Plasma
and erythrocyte GPX activities positively correlated with glucose,
cholesterol, and triglyceride concentrations. Liver superoxide dis-
mutase activity positively correlated with glucose and cholesterol
concentration. Vitamin E reduced plasma LPO, but did not affect
thediabeticstate.Thus,plasmaLPOwasthemostreliableindicator
of diabetes-induced oxidative stress. Antioxidant enzyme activities
and types of reactive oxygen species generated were tissue depen-
dent. Diabetes-induced oxidative stress is diminished by vitamin E
supplementation.
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Oxidative stress is a common consequence of diabetes mel-
litus [1–4]. Diabetic complications associated with oxidative
stress include nephropathy, neuropathy, retinopathy, and vascu-
lopathy[2,5–9].Approximately80%ofthedeathanddisability
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associated with diabetes is due to cardiovascular disease sec-
ondary to atherosclerosis [10]. Consequently, there is a great
deal of interest in understanding the role of oxidative stress in
these diabetic complications. However, the literature remains
unclear as to which biological measurements are the most re-
liable bioindicators of oxidative stress speciﬁcally associated
with diabetes. It is also uncertain as to whether there may be
tissue-speciﬁc responses to diabetes-induced oxidative stress.
Dietary supplementation with the antioxidant vitamin E has
beensuggestedasaplausiblemeansofcontrollingdiabeticcom-
plications [11, 12]. Conversely, others have shown that dietary
vitamin E supplementation is not useful in the prevention of
oxidative stress associated with diabetes [13, 14].
Toaddresstheseconcerns,atype1diabeticrabbitmodelwas
used to investigate various assays/tissues in order to identify a
reliable bioindicator of oxidative stress speciﬁcally associated
with diabetes. Secondly, the effect of dietary vitamin E supple-
mentation on diabetes-induced oxidative stress and the diabetic
state was investigated.
MATERIALS AND METHODS
Animals
Following a 7-day acclimation period, juvenile, male, New
Zealand White (NZW) rabbits (Charles River Laboratories,
Wilmington, MA, USA) were injected with alloxan mono-
hydrate (100 mg/kg body weight; Sigma, St. Louis, MO,
USA) via the marginal ear vein in order to induce type 1
diabetes. This is a well-characterized model of type 1 dia-
betes. Rabbits were injected subcutaneously every 4 to 6 hours,
for the ﬁrst 24 hours, with a 40% glucose solution (2 g/kg
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body weight) to prevent onset of acute hypoglycemia. Rab-
bits were randomly separated into 3 treatment groups: control
(n D 5), diabetic (n D 3), and diabetic C vitamin E (n D
4). All rabbits were fed rabbit chow (Harlan Teklad, Madi-
son, WI, USA) and water ad libitum. Two weeks after the
alloxan injection, the diabetic C vitamin E group received
a daily dietary supplement of vitamin E (500 mg/day; Bio-
Serve, Frenchtown, NJ, USA), whereas the control and dia-
betic groups received placebo tablets (Bio-Serve). Palatability
of the vitamin E and placebo supplements was excellent. Ex-
periments were performed in accordance with the Principles of
Laboratory Animal Care (NIH publication no. 85-23, revised
1995).
Body Weight and Tissue Collection
Initial experimental samples/measurements were obtained
prior to induction of diabetes or vitamin E supplementation.
Subsequent samples/measurements were taken at 2, 4, 8, and
12 weeks. Following assessment of body weight, whole blood
was collected via the central ear artery and transferred to a va-
cutainer tube (lavender cap with K3EDTA; Becton Dickinson,
Franklin Lakes, NJ, USA) and placed on ice. Plasma was col-
lected by centrifugation (400 £ g, 15 minutes, 10±C) and stored
at ¡80±C until needed for analysis. Erythrocytes were collected
and washed 3 times with phosphate-buffered saline (PBS) (pH
7.4). Erythrocytes were then sonicated on ice for 20 seconds,
centrifuged at 30,000 £ g for 30 minutes at 4±C, and then the
supernatants were stored at ¡80±C.
At12weeks,wholebloodwascollectedviacardiacpuncture
from anesthetized (ketamine 50 mg/kg C xylazine 10 mg/kg)
rabbits. Rabbits were then euthanized with a single cardiac in-
jection of Fatal Plus (concentrated pentobarbital, 360 mg/kg).
Livertissuewascollectedinto0.25mol/lsucroseandstoredim-
mediately on ice. Subsequently, liver tissue was homogenized
(Polytron, Brinkman Instruments, Westbury, NJ, USA) on ice
for 20 seconds at setting D 6; then centrifuged at 30,000 £ g for
30 minutes at 4±C. The supernatant was collected and stored at
¡80±C.
Blood Chemistries
Glucose, cholesterol, and triglyceride concentrations in
plasma were determined using commercially available kits
(Sigma).
Lipid Peroxidative Damage
Lipid peroxidative (LPO) damage was quantitated by mea-
suring thiobarbituric acid reactive substances (TBARS) in the
plasma,usingamodiﬁedmethodofAgiletal.[15].TheTBARS
assay is a routinely utilized method for assessing LPO [16–18].
The primary goal of this study was to determine a reliable
bioindicator of oxidative stress speciﬁcally associated with di-
abetes, not to quantitate the absolute amount of LPO. Brieﬂy,
for this method, 20 ¹l of plasma was combined with 4 ml of
0.08NH2SO4 and0.5mlof10%phosphotungsticacid(Sigma),
and centrifuged at 400 £ g for 20 minutes at 25±C. The pellet
was then resuspended in 2 ml 0.08 N H2SO4 and 0.5 ml of
10% phosphotungstic acid and centrifuged as before. The pellet
was then mixed with 1 ml of thiobarbituric acid assay reagent
(mixture of equal volumes of a 4.6 mol/l 2-thiobarbituric acid
[Sigma] aqueous solution and glacial acetic acid) and 4 ml of
ddH2O and placed in a boiling water bath for 60 minutes. Next,
5 ml of n-butanol was added and the tubes centrifuged as be-
fore for 30 minutes. Fluorescence of the butanol layer was mea-
sured at excitation and emission wavelengths of 515 nm and
553 nm, respectively, using a spectroﬂuorometer (model RF-
1501, Shimadzu, Japan). Malondialdehyde (MDA; Sigma) was
used to generate a standard curve and TBARS were expressed
as MDA equivalents (nmol)/ml plasma.
Glutathione Peroxidase Activity
Selenium-dependent glutathione peroxidase (GPX) activity
in plasma, erythrocytes, and liver was measured using a modiﬁ-
cationofthemethoddescribedbyPagliaandValentine[19].Us-
ing0.25mmol/lH2O2 assubstrate,theoxidationofNADPHwas
monitored over 180 seconds at 340 nm using a Shimadzu UV-
visiblespectrophotometer(Model160,Kyoto,Japan).Theassay
mixture contained 2 mmol/l glutathione, 0.25 mmol/l NADPH,
1Uofglutathionereductase,1.0mmol/lsodiumazide,1.5mol/l
EDTA, and 50 mmol/l potassium phosphate buffer (pH 7.0).
GPX activity is reported in mU/mg protein. Protein content of
the plasma (or tissue supernatant) was determined using a com-
merciallyavailableproteinquantitationassay(Bio-RadLabora-
tory, Richmond, CA, USA).
Superoxide Dismutase Activity
Total superoxide dismutase (SOD) activity was determined
in plasma, erythrocytes, and liver according to a modiﬁed assay
described by Pence and Naylor [20], in which the reduction of
cytochromecismeasuredover2minutesat550nmusingaShi-
madzu UV-visible spectrophotometer. Brieﬂy, 50 ¹l of sample
was combined with 940 ¹l of the assay mixture (0.023 mmol/l
cytochrome c [from horse heart, Sigma] and 0.04 mmol/l xan-
thine[Sigma]inbuffersolution[50mmol/lNaKPO4;0.1mmol/l
EDTA, pH 7.0]). To initiate the reaction, 0.18 U (or amount
needed to produce a change in absorbance/min D 0.020–0.030)
ofxanthineoxidase(gradeIII;Sigma)wasaddedtocuvette.One
unit of SOD activity was deﬁned as the amount of SOD needed
to inhibit the rate of cytochrome c reduction by 50% and wasDIABETES-INDUCED OXIDATIVE STRESS 187
expressed as units per milligram protein. Protein concentration
was determined as described above.
Statistical Analysis
All data are expressed as the mean § SEM. Analysis of
variance was used to determine if the treatments were signif-
icantly (P <0.05) different. The Newman-Keuls method was
used to separate means when signiﬁcant treatment effects were
observed.Linear-regressionanalysiswasusedtodeterminecor-
relations between blood chemistries and indicators of oxidative
stress. All statistical analyses were done using GraphPad Prism
2.0 (GraphPad Software, San Diego, CA, USA).
RESULTS
Blood Chemistries
Body weight was not signiﬁcantly different between treat-
ment groups through the ﬁrst 4 weeks of treatment. At 8 and
12 weeks, diabetic rabbits had signiﬁcantly lower body weights
than control rabbits, whereas body weights of diabetic C vita-
minErabbitswerenotsigniﬁcantlydifferentfromeithercontrol
or diabetic rabbits (Figure 1).
By 2 weeks, alloxan-treated rabbits were indeed diabetic, as
indicatedbyplasmaglucoselevelsgreaterthan300mg/dL(Fig-
ure 2A) and remained hyperglycemic throughout the 12 weeks
of the experiment. Dietary vitamin E supplementation had no
effect on plasma glucose levels, as glucose levels were not sig-
niﬁcantly different from those in diabetic rabbits (Figure 2A).
Althoughplasmacholesterolandtriglyceridelevelsexhibited
asimilarproﬁletothatofplasmaglucose,treatmentgroupswere
not signiﬁcantly different from controls (Figure 2B,2 C ). In-
deed, cholesterol and triglyceride data revealed large variability
FIGURE 1
Body weights of control, diabetic, and diabetic C
vitamin E–supplemented (500 mg/day) NZW rabbits over a
12-week period. Data represent mean § SEM (nD3–5). Data
points with different, lowercase superscripts are signiﬁcantly
(P <0.05) different and NS denotes nonsigniﬁcance.
FIGURE 2
Plasma glucose, cholesterol, and triglyceride levels of control,
diabetic, and diabetic C vitamin E–supplemented
(500 mg/day) NZW rabbits over a 12-week period. Data
represent mean § SEM (nD3–5). Data points with different,
lower case superscripts are signiﬁcantly (P <0.05) different,
NS denotes nonsigniﬁcance, and ? indicates missing data.188 R. L. DAVIS ET AL.
amongrabbits,resultingininconsistentdata.Oneexceptionwas
at 2 weeks, when plasma triglycerides were signiﬁcantly ele-
vated in the diabetic group (Figure 2C).
Nonenzymatic Indicators of Oxidative Stress
Oxidativestress,asindicatedbylipidperoxidation(TBARS)
in the plasma, was increased 2-fold at 12 weeks in the diabetic
group. The level of TBARSs in the vitamin E–supplemented
group was signiﬁcantly less than the diabetic group and not
different from the control group (Figure 3A).
Linear-regression analysis demonstrated a signiﬁcant posi-
tivecorrelationbetweenplasmaglucoseconcentrationandlevels
of plasma TBARS at 12 weeks (Figure 3B). However, neither
plasma cholesterol nor plasma triglyceride levels were corre-
lated with plasma TBARS (data not shown).
FIGURE 3
(A) Plasma lipid peroxidation (as determined by the TBARS
assay) in control, diabetic, and diabetic C
vitamin E–supplemented (500 mg/day) NZW rabbits following
a 12-week treatment period. (B) Correlation between plasma
lipid peroxidation and plasma glucose concentration after
12 weeks of treatment, as determined by linear regression
analysis. Data represent mean § SEM (nD3–5). Data points
with different, lowercase superscripts are signiﬁcantly
(P <0.05) different.
Enzymatic Indicators of Oxidative Stress
GPX activity was signiﬁcantly decreased at 12 weeks in the
liver of diabetic rabbits as compared to control rabbits, whereas
liver GPX activity in vitamin E–supplemented rabbits was not
signiﬁcantlydifferentfromeitheroftheother2treatmentgroups
(Figure 4A). Linear-regression analysis indicated a signiﬁcant,
negative correlation between plasma glucose concentration and
liver GPX activity at 12 weeks (Figure 4B). Plasma triglyc-
eride concentration was also negatively correlated (r2 D.5995,
P D.0086)withliverGPXactivityat12weeks,whereasplasma
cholesterol levels were not correlated with liver GPX activity
(data not shown).
GPX activity in plasma and erythrocytes was seemingly in-
creased in the diabetic and vitamin E–supplemented rabbits at
FIGURE 4
(A) Liver glutathione peroxidase (GPX) activity in control,
diabetic, and diabetic C vitamin E–supplemented (500
mg/day) NZW rabbits following a 12-week treatment period.
(B) Correlation between liver GPX activity and plasma glucose
concentration after 12 weeks of treatment, as determined by
linear-regression analysis. Data represent mean § SEM
(nD3–4). Data points with different, lowercase superscripts
are signiﬁcantly (P <0.05) different.DIABETES-INDUCED OXIDATIVE STRESS 189
FIGURE 5
(A) Liver superoxide dismutase (SOD) activity in control,
diabetic, and diabetic C vitamin E–supplemented
(500 mg/day) NZW rabbits following a 12-week treatment
period. (B) Correlation between liver SOD activity and plasma
glucose concentration after 12 weeks of treatment, as
determined by linear-regression analysis. Data represent
mean § SEM (nD3–5). Data points with different, lowercase
superscripts are signiﬁcantly (P <0.05) different.
12 weeks, however, not to the level of signiﬁcance (data not
shown). Liver SOD activity was increased approximately 2.5-
foldat12weeksinthediabeticgroupreceivingsupplementalvi-
taminE,comparedtocontrolrabbits(Figure5A).However,liver
SOD activity in the diabetic rabbits was not signiﬁcantly differ-
ent from the other 2 groups. Linear-regression analysis demon-
stratedasigniﬁcant,positivecorrelation(r2 D.3656, P D.0373;
Figure5B)betweenplasmaglucoseconcentrationandliverSOD
activity at 12 weeks. Plasma cholesterol and triglyceride were
not signiﬁcantly correlated with liver SOD activity. SOD ac-
tivity in the plasma and erythrocytes was similar among all 3
treatment groups at 12 weeks and not correlated with any of the
blood chemistries measured (data not shown).
DISCUSSION
Oxidative stress is a well-documented consequence of dia-
betes mellitus [6, 7, 21]. The purpose of the present study was
to evaluate which method/tissue would efﬁciently and reliably
detectoxidativestressspeciﬁcallyassociatedwithdiabetes.Sec-
ondly,theabilityofdietaryvitaminEsupplementationtoreduce
diabetes-induced oxidative stress and correct the diabetic state
wasexamined.Thereareseveralmethodscommonlyusedtode-
tect oxidative stress, including antioxidant enzyme status [22],
nonenzymaticantioxidantstatus[3],LPO[23],DNAadductfor-
mation[24],andisoprostanelevels[25].Typicaltissuesassayed
for oxidative stress include plasma, erythrocytes, pancreas, kid-
ney,andliver[20,26,27].AlthoughDNAadductformationand
isoprosanes are generally considered to be more speciﬁc, quan-
titativemeasuresofoxidativestress,theyareveryexpensiveand
relatively laborious. Therefore, we selected assays that are rou-
tinelyused,includingLPOandantioxidantenzymeactivity,due
totheireaseofperformance,repeatability,andcost-effectiveness
[16, 28, 29].
A single injection of alloxan was sufﬁcient to induce dia-
betes, as indicated by plasma glucose concentrations in the 400-
to 600-mg/dL range by 2 weeks after injection (Figure 2A).
Neither plasma cholesterol nor triglyceride concentrations were
consistently elevated by diabetes. The apparent partial recovery
of body weight in diabetic rabbits supplemented with vitamin E
was not the result of a vitamin E–induced decrease in diabetic
severity as deﬁned by blood glucose. Vitamin E had no signiﬁ-
cant effect on diabetic blood glucose levels.
LPO in the plasma, as determined by the TBARS assay, was
the most reliable indicator of diabetes-induced oxidative stress.
This appeared to be the case, as plasma LPO was the only mea-
sure of oxidative stress that was positively and signiﬁcantly
correlated with plasma glucose concentration, but not plasma
cholesterol or triglyceride concentrations, which were not con-
sistently or signiﬁcantly altered by the diabetic state.
The decrease in liver GPX activity at 12 weeks in diabetic
rabbits may be indicative of an exhaustion of GPX as a conse-
quence of increased oxidative stress. Similar decreases in liver
GPX activity have been found in streptozotocin (STZ)-induced
diabetic pregnant rats [30] and alloxan-induced diabetic rats
[31]. Conversely, others have documented increased liver GPX
activity associated with diabetes [32]. Liver GPX activity was
negatively correlated with plasma glucose and triglyceride con-
centration but not plasma cholesterol. In contrast, GPX activity
in the plasma and erythrocytes was not signiﬁcantly affected by
the diabetic state.
Decreased pancreatic GPX activity, with concurrent normal
erythrocyte and plasma GPX activity, has been documented in
prediabetic diabetic-prone BB rats [20]. These data further in-
dicate that the response of GPX to oxidative stress appears to
be tissue dependent, and, with respect to the liver, the literature
suggests GPX activity is quite variable in response to oxidative
stress[30–32].Baseduponthedatapresentedhere,aswellasthe190 R. L. DAVIS ET AL.
literature,GPXactivitydoesnotappeartobeareliableindicator
of diabetes-associated oxidative stress.
SOD activity was quite variable in all the tissues assessed,
and, although correlated with the hyperglycemic state, the mag-
nitude of the response was small and not signiﬁcant, there-
fore, preempting SOD activity from reliably reﬂecting diabetic-
induced oxidative state. Recently, Ruiz and colleagues [33]
found that patients with type 1 diabetes had increased oxidative
stress, as indicated by increased LPO; however, SOD activity
was unaffected. In contrast, pregnant women with type 1 di-
abetes had decreased plasma SOD activity with a concurrent
elevation in plasma LPO [34]. Wohaieb and Godin [35] suggest
that the variable alterations in antioxidant enzyme activities in
varioustissuesmayreﬂectacompensatoryresponseinthosetis-
sues that typically possess low levels of a particular enzyme and
aninhibitoryorexhaustiveeffectintissueswithincreasedtissue
oxidant activity. Given that the substrates for GPX and SOD are
different (hydrogen peroxide and superoxide, respectively), the
differentialresponseofthese2enzymestodiabetes-inducedox-
idative stress may reﬂect differences in reactive oxygen species
generated.
Evaluation of the various indicators of oxidative stress mea-
sured in the present study suggests that, in this rabbit model
of type 1 diabetes, plasma LPO is a more reliable indicator
of diabetes-induced oxidative stress than either GPX or SOD
activity.
Vannucchi and colleagues [12] recently found in STZ-
induced diabetic rats that vitamin E deﬁciency resulted in el-
evated LPO (as indicated by the TBARS assay), whereas vi-
tamin E supplementation protected from LPO and returned
glucose levels to normal. Similarly, vitamin E supplementa-
tion (100 IU/day) in patients with type 1 diabetes resulted in
a 30% decrease in LPO as determined by the TBARS assay
[36]. These investigators did not report blood glucose data fol-
lowing vitamin E supplementation; however, they did indicate
insulin use by the patients was unaffected [36]. Data from the
present study demonstrate that dietary vitamin E supplemen-
tation (500 IU/day) was sufﬁcient to reduce diabetes-induced
oxidative stress, but not plasma glucose concentration.
Control of diabetes-induced oxidative stress could theoreti-
cally be used to reduce the severity of diabetic complications.
The antioxidant vitamin E has received much attention for its
potentialroleincontrollingoxidativestress[11,12,37].Withre-
specttodietaryvitaminEanddiabetes-inducedoxidativestress,
there is still much to be learned. Palmer and colleagues [37]
found that vitamin E supplementation in STZ-induced diabetic
rats decreased oxidative stress, as indicated by reduced levels
of 8-epi prostaglandin F2 alpha in the plasma. Relatively high
doses of vitamin E (900 mg/day for 4 months) have been found
to reduce oxidative stress in diabetic patients, as determined
by an indirect measurement of serum oxygen generation us-
ing a ferricytochrome c reduction–based assay, in the presence
and absence of SOD [38]. Likewise, Astley and colleagues [27]
measured DNA single-strand breaks in peripheral lymphocytes
and susceptibility to hydrogen peroxide–induced stress (comet
assay) as an indicator of oxidative stress, and found that di-
abetic patients were protected by vitamin E supplementation
(400 IU/day for 8 weeks). Although there are studies that ques-
tion the protective effects of vitamin E in the diabetic [39], the
current study and those referred to above would indicate that
an appropriate dose of vitamin E can modify diabetes-induced
oxidative stress.
In conclusion, we have demonstrated in a rabbit type 1 dia-
betes model that plasma LPO is a reliable indicator of diabetes-
induced oxidative stress, as it was positively correlated with
plasma glucose concentration, but not with the variable plasma
cholesterol or triglyceride concentrations. Conversely, the an-
tioxidant enzyme (GPX and SOD) activities tested were less
reliable bioindicators of oxidative stress speciﬁcally associated
with diabetes. Dietary vitamin E supplementation signiﬁcantly
reduced diabetes-induced oxidative stress (as indicated by a de-
crease in plasma LPO), but had no effect on the hyperglycemic
state. These ﬁndings support the role of dietary antioxidant sup-
plementation in the prevention of diabetes-induced oxidative
stress, and suggest a potential therapeutic beneﬁt for the reduc-
tion of diabetic complications associated with oxidative stress.
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